The Global Ophthalmoplegia Market is expected to grow at a CAGR of 7.5% during the forecast period of 2018 to 2025.
FREE Sample report is instantly available at @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-ophthalmoplegia-market
Global Ophthalmoplegia Market
By Product Type
External Opthalmoplegia,
Internuclear Opthalmoplegia
By Treatment
• Surgery,
• Drug Treatment
By End User
• Hospitals,
• Clinics,
• Ambulatory Centeres
By Geography
• North America,
• South America,
• Europe,
• Asia-Pacific,
• Middle East and Africa
Report Can Be Provided as per Organization Requirement at @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ophthalmoplegia-market
Global Ophthalmoplegia Market
Ophthalmoplegia is an eye disorder in which one or more of the six muscles of the eye got affected and thus causing it to weakness of the eye muscles which ultimately leads to eye paralysis. This disorder can be congenital or also can be developed later in life. Few common causes include brain tumor, migraine, thyroid disease, stroke, infection in the eye and any kind of brain injuries.
In this condition, nerve fibers that coordinate both eyes in horizontal movements looking from side to side- are damaged. Multiple devices and treatement are available in the market which can cure or improve the eyesight of the patients.. As there is increase in geriatric polulation as well as increasing cases of opthalmoplegia the global ophthalmoplegia market is showing a vast growth. . According to the World Health Organization in 2010, about 250 million people of over 50 years were suffering from visual impairment. Around 80% people in many of the developing countries have eye sight problems; of which nearly 50% of the people are not able to take treatment due to huge cost of the surgeries.. The major cause for ophthalmoplegia is diabetes. Increasing prevalence of ophthalmoplegia, changing lifestyle are the major driver for the growth of the market. Moreover, increasing prevalence of diabetes & other neurological diseases, and increasing government support for research & development have fueled the market growth.
FACTORS DRIVING GROWTH IN THE GLOBAL OPTHALMOPLEGIA MARKET
Rising number of diseases including strokes, thyroid disease, and brain tumor:
From multiple studies it was found that the incidence of the brain tumors are increasing.. Brain tumors diagnosed in the period 1985-2005 were identified through the Tuscan Cancer Registry, a population-based registry active since 1985 in the area of Florence and Prato. Age-standardized incidence rates and average annual percent change (APC) was calculated for the entire period from 1985 to 2005 for sex and behavior. A total of 4,417 brain tumors was registered, 1,900 (43.0%) in male and 2,517 (57.0%) in female patients. Malignant and benign tumor incidence rates were 8.3 and 4.1, respectively, among males and 6.4 and 7.2, respectively, among females.
In one study, a new analysis of data collected by the National Cancer Institute’s nationwide cancer surveillance program, researchers at the National Institute on Aging in Bethesda, Md., have determined that among people over the age of 75, the incidence of brain tumors more than doubled from 1968 to 1985, the last year for which statistics are available. For people over 80, the rate of increase was even more shocking, soaring by 30.0% to 40.0% over the 17-year period, or by as much as 23.0% a year.
National Research Council in Washington, the Karolinska Institute in Stockholm and other institutions recently compared mortality figures from about 1968 to 1987 for the United States, Britain, Italy, France, West Germany and Japan. They found that among people 65 and older, deaths from brain tumors rose in all nations at up to 200% for the period.
FREE TOC is available at @ https://databridgemarketresearch.com/toc/?dbmr=global-ophthalmoplegia-market
Thyroid Disease:
Thyroid Epidemiological Study team in India revealed that one in ten adults in India suffers from hypothyroidism, with 50.0%being women. The study which went on for nine months was carried on 5,360 patients residing in eight different cities in India, aged 18 years or over.
There are two types of Thyroid diseases – Hypothyroidism and Hypethyroidism, while the later is rarely found, Hypothyroidism was highly prevalent amongst the surveyed population (10.95%). The older population suffer more thyroid condition than the younger population. Women were three times more likely to be affected by hypothyroidism than men (15.86% vs. 5.02%), especially those in the age group (46-54 years). Hypertension (20.4%) and diabetes mellitus (16.2%) were the other common diseases observed in the study
Some of the major players operating in global Ophthalmoplegia market are
• Abbott,
• Novartis AG,
• ZEISS International,
• Valeant,
• Amritt, Inc.,
• Medline Industries, Inc.,
• ALLERGAN,
• Johnson & Johnson Private Limited,
• F. Hoffmann-La Roche Ltd,
• Valeant,
• Santen Pharmaceutical Co., Ltd,
• TOPCON CORPORATION,
• NIDEK CO., LTD,
• HOYA Corporation,
• Essilor.
For more information about this report visit @ https://databridgemarketresearch.com/news/product-launch/global-ophthalmoplegia-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]